Dr. Michael Ellis, an infectious disease specialist and chief medical officer at UTMC, talks about the hospital’s participation in a nationwide NIH study examining a pair of monoclonal antibodies to treat COVID-19. The study is aimed at quickly identifying therapeutics worthy of larger clinical trials.
